Please login to the form below

Not currently logged in
Email:
Password:

Shire’s Dr Armin Reininger moves to Sobi

Appointed as senior vice president, head of global medical and scientific affairs

Sobi Dr Armin ReiningerStockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs.

Dr Reininger joins the rare diseases specialist from Shire, where he most recently served as head of medical affairs for haematology, EMEA at Baxalta, having first joined Baxter as head of global medical affairs for haemophilia.

Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

Geoffrey McDonough, president and chief executive officer at Sobi, said: “We are truly delighted to welcome Armin to Sobi.

“Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”

17th January 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics